6 results
Search Results
2. Chimioradiothérapie postopératoire des cancers des voies aérodigestives : vers un nouveau standard ?
- Author
-
Zouhair, A., Matzinger, O., Azria, D., Gaye, M.P., Ugurluer, G., El Hfid, M., Mirimanoff, R.O., and Ozsahin, M.
- Subjects
- *
CANCER treatment , *SQUAMOUS cell carcinoma , *HEAD & neck cancer , *CANCER chemotherapy , *CANCER radiotherapy , *ADJUVANT treatment of cancer , *POSTOPERATIVE care , *CANCER prognosis - Abstract
Abstract: Head and neck squamous cell carcinomas are frequently diagnosed at an advanced stage. Their treatment remains controversial, and has to be multidisciplinary. External beam radiotherapy is a recognized treatment option after radical curative surgery in order to improve local control. Different adjuvant treatment options have been studied in order to improve the outcome of these patients. We review in this paper the different prognostic factors indicating an adjuvant treatment and the interest of treatment intensification in bad prognostic patients. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
3. Cancer de l’estomac : doses et volumes-cibles
- Author
-
Hennequin, C., Quero, L., and Mineur, L.
- Subjects
- *
CANCER chemotherapy , *STOMACH cancer treatment , *CANCER relapse , *CANCER treatment , *CANCER radiotherapy - Abstract
Abstract: Post-operative concomitant chemoradiotherapy is now a standard of care for locally advanced gastric carcinomas. Definition of target volumes is based on natural history of the disease and on analysis of the sites of local relapses. This paper summarized the general principles of target delineation, in a conformal approach. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
4. Vers une «politique sécurité» en oncologie–radiothérapie. La mise en œuvre du retour d'expérience
- Author
-
Woynar, S., Debouck, F., Cellier, P., Bourhis, J., Cauterman, M., and Lartigau, E.
- Subjects
- *
ONCOLOGY , *RADIATION , *TUMOR treatment , *CANCER treatment , *MEDICAL technology - Abstract
Abstract: Large modifications are on going in our medical practice in oncology (cancer incidence, ageing, rules, authorizations, billings…). To obtain the best results as possible implies a quality control of the equipments (drugs, machines…), of the professionals (certification) and of the organisations (accreditations). Radiation oncology plays a key role in the multidisciplinary treatment of cancer ant is very sensitive to quality assurances due to its specificities: different tumours, various patients, multiple sequences of treatment with high tech machines and information systems. From 2003, a progress policy has been developed with the MeaH (Mission d''évaluation et d''audit hospitalier). Rapidly, the transfer of security policies from industry to medicine has been considered. This paper will present the first results and their potential implications in the field of oncology. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
5. Traitement des cancers du poumon localisés au thorax
- Author
-
Depierre, A. and Westeel, V.
- Subjects
- *
SMALL cell lung cancer , *CANCER treatment , *DRUG therapy , *LUNG surgery , *LUNG cancer - Abstract
Abstract: This paper focuses on stage I, II and IIIA non-small cell lung cancer treatable with local treatment. It addresses five questions raised by strategies combining local treatments with chemotherapy. Even if chemotherapy increases resectability of stage III disease, the chemotherapy-surgery combination has not been demonstrated to increase survival compared to the standard chemo-radiation treatment. The results of the study by Van Meerbeeck do not support this hypothesis. Does surgery, added to chemo-radiotherapy, improve the outcome in stage IIIAN2 disease? This was the question addressed by the study by K. Albain. There is probably not clear cut answer. However, the trimodality strategy might be interesting in patients undergoing a lobectomy and might have a negative impact when a pneumonectomy has been performed. In patients with a non resectable/inoperable cancer treated with standard chemoradiation, the concomitant strategy has been shown to be superior to sequential treatment. However, due to acute toxicity, it should be delivered to selected patients, who still need to be better defined. The chemotherapy-surgery combination is becoming standard (in stage II disease) and most cooperative groups will probably stand in favour of it in 2006. The best respective timing for chemotherapy and surgery is still debated. There are many advantages in favour of preoperative chemotherapy, including better feasibility and the higher proportion of patients who can benefit. However, there is no statistically reliable demonstration of such superiority. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
6. Bases génétiques de la radiosensibilité des cancers du sein
- Author
-
Delaloge, S. and Marsiglia, H.
- Subjects
- *
RADIOTHERAPY , *ELECTROTHERAPEUTICS , *BREAST cancer , *CANCER radiotherapy , *CANCER treatment - Abstract
Abstract: Local-regional radiation therapy is one of the major therapeutic means in the management of breast cancer. Three questions however arise from the important advances achieved in this domain in the past years. The first question concerns the possibilities to identify and overcome the radioresistance of a subset of tumours. The second question is how to recognize women likely to benefit from adjuvant radiation therapy, and therefore to diminish treatment indications in other groups. Finally, the third question is how to identify subjects at high risk for long term injury following breast irradiation, in order to adapt techniques and indications in such populations. The major advances of breast cancer molecular genetics in the past years should provide clinicians with tools to answer these important questions. In this paper, we review the molecular germline (BRCA1, BRCA2, ATM, …) and somatic (p53, tyrosine kinase receptors, as well as actors of cell cycle, signal transduction, apoptosis, DNA repair …) main bases of breast cancer radiosensitivity. Recent methods of exploration of the genetic background of both the host and the tumours (gene and protein expression profiles) are also reviewed as major tools of breast cancer management in the next few years. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.